Sep 2026
Empagliflozin Improves Atherosclerosis by Promoting Mitophagy in Endothelial Cells.
EMPA inhibits the progression of AS by activating Pink1/Parkin-mediated mitophagy, thereby improving mitochondrial function and alleviating endothelial injury and providing a novel basis for the cardiovascular protective mechanisms of EMPA.
Long-Long Yan, Jing-Jing Lu, Wen-Dong Xu et al.
· Cardiovascular Drugs and The... · 0 citations